Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950123-10-088826
Filing Date
2010-09-24
Accepted
2010-09-24 16:05:04
Documents
6
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A a56395e10vkza.htm 10-K/A 987043
2 EX-23.1 a56395exv23w1.htm EX-23.1 2183
3 EX-31.1 a56395exv31w1.htm EX-31.1 8069
4 EX-31.2 a56395exv31w2.htm EX-31.2 8580
5 EX-32.1 a56395exv32w1.htm EX-32.1 4322
6 EX-32.2 a56395exv32w2.htm EX-32.2 4060
  Complete submission text file 0000950123-10-088826.txt   1015871
Mailing Address 2492 WALNUT AVENUE STE 100 TUSTIN CA 92780
Business Address 2492 WALNUT AVENUE STE 100 TUSTIN CA 92780 7145054460
RADIENT PHARMACEUTICALS Corp (Filer) CIK: 0000838879 (see all company filings)

EIN.: 330413161 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-16695 | Film No.: 101088954
SIC: 2834 Pharmaceutical Preparations